Find clinical trials for Prostate Cancer in Phoenix, AZ
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Prostate Cancer trials near Phoenix, AZ, USA:
to as AAA617. The study also seeks to further characterize (as possible) any other serious adverse reaction(s) in the long-term in adults with prostate...
Phase 4
Scottsdale, Arizona, United States and 53 other locations
radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stim...
Phase 3
Phoenix, Arizona, United States and 72 other locations
of vudalimab (XmAb20717) alone or in combination with standard of care anticancer therapies in patients with metastatic castration-resistant prostate...
Phase 2
Phoenix, Arizona, United States and 25 other locations
This is a Phase 1a, first-in-human, open-label dose-escalation study to determine the RDR and/or MTD, and to assess the DLT of INV-9956. The safety,...
Phase 1
Scottsdale, Arizona, United States and 3 other locations
plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednison...
Phase 2, Phase 3
Phoenix, Arizona, United States and 112 other locations
of the Vanquish Water Vapor Ablation Device ("Vanquish") in treating subjects with Gleason Grade Group 2 (GGG2) localized intermediate-risk prostate...
Phoenix, Arizona, United States and 32 other locations
The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...
Phase 3
Chandler, Arizona, United States and 388 other locations
activity of RO7656594 in participants with advanced or metastatic prostate cancer. It will also identify recommended doses and regi...
Phase 1
Scottsdale, Arizona, United States and 16 other locations
in participants with high-risk, localized or locally advanced prostate cancer receiving primary radiation therapy (RT) results in a...
Phase 3
Scottsdale, Arizona, United States and 271 other locations
The aim for this study is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases.
Phase 3
Phoenix, Arizona, United States and 18 other locations
Clinical trials
Research sites
Resources
Legal